ISSUER DOSSIER · CIK 0001847345

Aspire Biopharma Holdings, Inc. (ASBP, ASBPW)

Issuer profile2 captured filing nodes

Business context

Official SEC registration filing — S-1/A. Read the linked SEC filing for business, risk factors and offering details.

First captured2025-09-26

Latest filingS-1/A · 2026-04-10

Registration path0 initial filings · 2 amendments

Compare the next amendment against the current filing, then monitor for EFFECT or 424B. Material offering terms can change between amendments.

Latest captured filing: S-1/A · 2026-04-10 · 111 days ago.